Status:
COMPLETED
Zhongshan Iridocorneal Endothelial Syndrome Study (ICEs)
Lead Sponsor:
Sun Yat-sen University
Collaborating Sponsors:
ICE study group
Conditions:
Glaucoma
Eligibility:
All Genders
Brief Summary
This is a multi-center study to report the demographic profile, clinical features, and management in patients with Iridocorneal endothelial (ICE) syndrome in China.
Eligibility Criteria
Inclusion
- Clinical diagnosis of ICE syndrome;
- Those willing to sign the informed consent.
Exclusion
- Patients who don't sign the informed consent or abide by the study procedure.
Key Trial Info
Start Date :
September 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT03270761
Start Date
September 10 2017
End Date
December 31 2019
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, China, 510060